Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Lukas Ronner"'
Autor:
Corbett T. Berry, MD, PhD, Katarina G. Berry, MS, RD, LDN, James Abbott, MD, Angela J. Jiang, MD, Lukas Ronner, MD, MSc, Nicholas K. Mollanazar, MD, Robin Canada, MD, Douglas J. Pugliese, MD, MPH, Temitayo A. Ogunleye, MD
Publikováno v:
JAAD Case Reports, Vol 22, Iss , Pp 27-30 (2022)
Externí odkaz:
https://doaj.org/article/9c095db365a247c991d081acb0fcd979
Autor:
Douglas Tremblay, Andrew Srisuwananukorn, Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark L. Heaney, Andrew Kuykendall, Casey L. O’Connell, Jamile M. Shammo, Angela Fleischman, Ruben Mesa, Abdulraheem Yacoub, Ronald Hoffman, Erin Moshier, Nicole Zubizarreta, John Mascarenhas
Publikováno v:
HemaSphere, Vol 6, Iss 6, p e721 (2022)
Externí odkaz:
https://doaj.org/article/eb659d2d1c934eb5b98d002777108828
Publikováno v:
Blood Advances, Vol 3, Iss 20, Pp 3010-3012 (2019)
Externí odkaz:
https://doaj.org/article/221e6736ae394dccac56488f55a0c536
Autor:
Chen Zhang, Douglas Tremblay, John Magnotti, Lukas Ronner, Nikolai A. Podoltsev, Jason Gotlib, Mark L. Heaney, Andrew Kuykendall, Casey L. O'Connell, Angela G Fleischman, Ruben Mesa, Abdulraheem Yacoub, John Mascarenhas, Jamile M. Shammo
Publikováno v:
Blood. 140:9693-9695
Autor:
Sarah F. Adams, Phyllis A. Gimotty, Lukas Ronner, Gina Mantia-Smaldone, Nicole A. Marjon, Dallas B. Flies, Tomoe Higuchi
Treatment diagram for the combination therapy protocol.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1b120c83fd12bdd577d7b1e7b8b2f5
https://doi.org/10.1158/2326-6066.22538413.v1
https://doi.org/10.1158/2326-6066.22538413.v1
Autor:
Sarah F. Adams, Phyllis A. Gimotty, Lukas Ronner, Gina Mantia-Smaldone, Nicole A. Marjon, Dallas B. Flies, Tomoe Higuchi
PARP inhibition and CTLA-4 mAb combination therapy is ineffective against a BRCAwt cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae25fd26e4f326cd47f2c99229913c18
https://doi.org/10.1158/2326-6066.22538407
https://doi.org/10.1158/2326-6066.22538407
Autor:
Sarah F. Adams, Phyllis A. Gimotty, Lukas Ronner, Gina Mantia-Smaldone, Nicole A. Marjon, Dallas B. Flies, Tomoe Higuchi
Immune checkpoint blockade has shown significant therapeutic efficacy in melanoma and other solid tumors, but results in ovarian cancer have been limited. With evidence that tumor immunogenicity modulates the response to checkpoint blockade, and data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdfa2cda4d2db9e9318d09f7a1dac1e3
https://doi.org/10.1158/2326-6066.c.6548776.v1
https://doi.org/10.1158/2326-6066.c.6548776.v1
Publikováno v:
The Lancet Haematology. 8:e605-e612
Summary Polycythaemia vera is a challenging disease to study given its low prevalence and prolonged time-to-event for important clinical endpoints such as thrombosis, progression, and mortality. Although researchers in this space often rise to meet t
Autor:
Lukas Ronner, Heather M. Giannini, Todd A. Miano, Caroline A.G. Ittner, Alexandra P. Turner, Thomas G. Dunn, Roseline S. Agyekum, Anushka Dasgupta, Kirsten West, Tiffanie K. Jones, Michael G.S. Shashaty, John P. Reilly, Nuala J. Meyer
Publikováno v:
Blood. 140:6073-6074
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis
Autor:
Lukas Ronner, Angela G. Fleischman, Ruben A. Mesa, Matthew Chiaramonte, John Mascarenhas, Jason Gotlib, Revathi Kollipara, Mark L. Heaney, Mahta Salehi, Jenny Nguyen, Megan Randall, Cecelia Perkins, Douglas Tremblay, Robyn M. Scherber, Olivia Siwoski, Casey O'Connell, Nikolai A. Podoltsev, Annie Kwok Hung, Lindsey Behlman, Kimia Ziadkhanpour, Andrew T. Kuykendall, Shelby Meckstroth, Ami Dave, Erin Moshier, Jamile M. Shammo, Ronald Hoffman, Michelle Janania Martinez, Mitchell Harrison, Sagar Patel, Paola Fernandez Soto, Michael P. Grant, Hellen Nguyen, Abdulraheem Yacoub
Publikováno v:
Blood. 135:1696-1703
There are unresolved questions regarding the association between persistent leukocytosis and risk of thrombosis and disease evolution in polycythemia vera (PV), as much of the published literature on the topic does not appropriately use repeated-meas